Drug recall D-0894-2023
Product
Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC: 68788-7781-3), c) 60-count bottles, (NDC: 68788-7781-6), d) 90-count bottles (NDC: 68788-7781-9), e) 120-count bottles (NDC: 68788-7781-8), Rx only, Mfg: Dr. Reddy's Laboratories Limited.
Reason for recall
Failed Stability Specifications
Lots and codes
Lot#: a) H1621S, Exp: 12/31/2023; b) H2321C, Exp: 12/31/2023; c) H0421B, Exp: 12/31/2023; d) H1721E, H1921T, H3121M, Exp: 12/31/2023, e) H2021G, Exp: 12/31/2023
Recall details
- Recalling firm
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Quantity
- 541 Bottles
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- June 26, 2023
Related products
- Tizanidine – drug information
- NDC 68788-7781 Tizanidine · Tizanidine Hydrochloride 4 mg/1 · Preferred Pharmaceuticals, Inc.